On Monday, Actinium Pharmaceuticals Inc (AMEX: ATNM) opened higher 14.17% from the last session, before settling in for the closing price of $1.27. Price fluctuations for ATNM have ranged from $1.03 to $2.41 over the past 52 weeks.
A company in the Healthcare sector has jumped its sales by 21.99% annually for the last half of the decade. Company’s average yearly earnings per share was noted 12.80% at the time writing. With a float of $30.22 million, this company’s outstanding shares have now reached $31.20 million.
Actinium Pharmaceuticals Inc (ATNM) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Actinium Pharmaceuticals Inc is 3.12%, while institutional ownership is 18.94%.
Actinium Pharmaceuticals Inc (ATNM) Latest Financial update
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -0.21 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.39) by 0.18. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.11 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 12.80% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 23.44% during the next five years compared to 21.99% growth over the previous five years of trading.
Actinium Pharmaceuticals Inc (AMEX: ATNM) Trading Performance Indicators
Check out the current performance indicators for Actinium Pharmaceuticals Inc (ATNM). In the past quarter, the stock posted a quick ratio of 7.96. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 502.62.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.11, a number that is poised to hit -0.20 in the next quarter and is forecasted to reach -0.66 in one year’s time.
Technical Analysis of Actinium Pharmaceuticals Inc (ATNM)
Let’s dig in a bit further. During the last 5-days, its volume was 0.4 million. That was better than the volume of 0.36 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 31.00%.
During the past 100 days, Actinium Pharmaceuticals Inc’s (ATNM) raw stochastic average was set at 33.33%, which indicates a significant decrease from 59.46% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0800 in the past 14 days, which was lower than the 0.0924 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.5096, while its 200-day Moving Average is $1.4845. However, in the short run, Actinium Pharmaceuticals Inc’s stock first resistance to watch stands at $1.5833. Second resistance stands at $1.7167. The third major resistance level sits at $1.8333. If the price goes on to break the first support level at $1.3333, it is likely to go to the next support level at $1.2167. The third support level lies at $1.0833 if the price breaches the second support level.
Actinium Pharmaceuticals Inc (AMEX: ATNM) Key Stats
There are currently 31,196K shares outstanding in the company with a market cap of 45.24 million. Presently, the company’s annual sales total 0 K according to its annual income of -38,240 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -6,880 K.
